Is GERN A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilities...
Geron Corp (GERN)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 30,126,299 | $42,478 | 0.68% | |
| 2. | Burrage Capital Management Christiana Goh Bardon | 1,912,673 | $2,697 | 2.7% | |
| 3. | Millennium Management Israel Englander | 899,161 | $1,268 | -27% | 0% |
| 4. | 228,500 | $322 | +175% | 0% | |
| 5. | Citadel Investment Group Ken Griffin | 213,536 | $301 | +147% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.73 | 17,441 | Director | 19,641 | 2020-08-21 | Filing | |
| $1.34 | 2,200 | Director | 2,200 | 2020-01-10 | Filing | |
| $1.35 | 800 | Director | 800 | 2020-01-10 | Filing | |
| $1.75 | 142,776 | Director | 142,776 | 2014-05-09 | Filing | |
| $1.03 | 50,000 | Officer, Director | 125,000 | 2013-04-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.00 | 120,635 | Officer | 0 | 2019-04-09 | Filing | |
| $6.85 | 35,000 | Director | 65,576 | 2018-09-13 | Filing | |
| $6.85 | 35,000 | Director | 65,576 | 2018-09-13 | Filing | |
| $6.85 | 35,000 | Director | 65,576 | 2018-09-13 | Filing | |
| $6.85 | 15,000 | Director | 65,576 | 2018-09-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 276,819 | $390,314 | 0% | |
| 2. | 34,302 | $48,366 | 0% | |
| 3. | 25,320,078 | $35,702 | 0% | |
| 4. | 15,667,341 | $22,091 | 0% | |
| 5. | 13,608,719 | $19,188 | 0% |
News See All
Is Geron Corporation (GERN) Going to Burn These Hedge Funds?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Market Movers Today: Alnylam Pharmaceuticals, Inc. (ALNY), Snap Inc (SNAP), Sellas Life Sciences Group Inc (SLS), Intel Corporation (INTC), and More
What happened: Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a precommercial pioneer of RNA-based therapies, continued a slide that began just ahead of the weekend.
Market Movers Today: Tesla Inc (TSLA), Amazon.com, Inc. (AMZN), Edge Therapeutics Inc (EDGE), Lululemon Athletica inc. (LULU), and More
NEW YORK, March 28 (Reuters) - Tesla Inc shares fell more than 9 percent on Wednesday following a downgrade by Moody’s Investors Service, a probe by the National Transportation Safety Board of a recent...
Market Movers Today: Dropbox, Inc. (DBX), Micron Technology, Inc. (MU), New York & Company, Inc. (NWY), Geron Corporation (GERN), and More
(Reuters) - Dropbox Inc’s shares soared by as much as 50 percent in their first day of trading on Friday as investors rushed to buy into the biggest technology initial public offering in more than a...
Market Movers Today: Facebook, Inc. (FB), Geron Corporation (GERN), Heron Therapeutics Inc (HRTX), Micro Focus International PLC – ADR (MFGP), and More
Facebook Inc.'s stock tumbled Monday after the social media company accused a data analytics firm used by the Trump campaign of exploiting ill-gotten data belonging to unwitting Facebook users.
40 Fresh Stories to Know How is it Going in the Financial Markets Today
"U.S. equities traded mostly lower on Friday as investors digested a tough week for retailers as well as mixed economic data.
What Is Happening In Financial Markets Today?
"U.S. equities advanced slightly on Monday amid geopolitical tensions while investors looked ahead to the start of earnings season.
Johnson & Johnson (JNJ)’s Janssen Builds On Partnership With Geron Corporation (GERN)
Janssen Pharmaceuticals, a subsidiary of the giant manufacturing company, Johnson & Johnson (NYSE:JNJ) has expanded the current partnership with the long-beleaguered Geron Corporation (NASDAQ:GERN).
Billionaire Hedge Funds
